S&P 500   3,056.38 (-1.93%)
DOW   26,475.39 (-1.79%)
QQQ   211.62 (-2.25%)
AAPL   284.50 (-2.78%)
FB   191.99 (-2.64%)
MSFT   166.17 (-2.35%)
GOOGL   1,351.73 (-2.79%)
CGC   19.22 (-3.03%)
NVDA   260.20 (-2.78%)
BABA   205.56 (-1.52%)
MU   51.30 (-2.04%)
GE   10.64 (-2.83%)
TSLA   727.85 (-6.54%)
AMD   46.12 (-2.88%)
T   36.76 (-0.92%)
ACB   1.44 (-4.64%)
F   7.05 (-2.22%)
NFLX   380.54 (+0.34%)
PRI   117.01 (-2.61%)
BAC   29.54 (-3.56%)
DIS   119.87 (-2.83%)
GILD   78.16 (+4.63%)
S&P 500   3,056.38 (-1.93%)
DOW   26,475.39 (-1.79%)
QQQ   211.62 (-2.25%)
AAPL   284.50 (-2.78%)
FB   191.99 (-2.64%)
MSFT   166.17 (-2.35%)
GOOGL   1,351.73 (-2.79%)
CGC   19.22 (-3.03%)
NVDA   260.20 (-2.78%)
BABA   205.56 (-1.52%)
MU   51.30 (-2.04%)
GE   10.64 (-2.83%)
TSLA   727.85 (-6.54%)
AMD   46.12 (-2.88%)
T   36.76 (-0.92%)
ACB   1.44 (-4.64%)
F   7.05 (-2.22%)
NFLX   380.54 (+0.34%)
PRI   117.01 (-2.61%)
BAC   29.54 (-3.56%)
DIS   119.87 (-2.83%)
GILD   78.16 (+4.63%)
S&P 500   3,056.38 (-1.93%)
DOW   26,475.39 (-1.79%)
QQQ   211.62 (-2.25%)
AAPL   284.50 (-2.78%)
FB   191.99 (-2.64%)
MSFT   166.17 (-2.35%)
GOOGL   1,351.73 (-2.79%)
CGC   19.22 (-3.03%)
NVDA   260.20 (-2.78%)
BABA   205.56 (-1.52%)
MU   51.30 (-2.04%)
GE   10.64 (-2.83%)
TSLA   727.85 (-6.54%)
AMD   46.12 (-2.88%)
T   36.76 (-0.92%)
ACB   1.44 (-4.64%)
F   7.05 (-2.22%)
NFLX   380.54 (+0.34%)
PRI   117.01 (-2.61%)
BAC   29.54 (-3.56%)
DIS   119.87 (-2.83%)
GILD   78.16 (+4.63%)
S&P 500   3,056.38 (-1.93%)
DOW   26,475.39 (-1.79%)
QQQ   211.62 (-2.25%)
AAPL   284.50 (-2.78%)
FB   191.99 (-2.64%)
MSFT   166.17 (-2.35%)
GOOGL   1,351.73 (-2.79%)
CGC   19.22 (-3.03%)
NVDA   260.20 (-2.78%)
BABA   205.56 (-1.52%)
MU   51.30 (-2.04%)
GE   10.64 (-2.83%)
TSLA   727.85 (-6.54%)
AMD   46.12 (-2.88%)
T   36.76 (-0.92%)
ACB   1.44 (-4.64%)
F   7.05 (-2.22%)
NFLX   380.54 (+0.34%)
PRI   117.01 (-2.61%)
BAC   29.54 (-3.56%)
DIS   119.87 (-2.83%)
GILD   78.16 (+4.63%)
Log in

NYSE:CC - Chemours Stock Price, Forecast & News

$14.40
-1.15 (-7.40 %)
(As of 02/27/2020 09:44 AM ET)
Today's Range
$14.11
Now: $14.40
$15.00
50-Day Range
$13.87
MA: $16.49
$19.70
52-Week Range
$11.71
Now: $14.40
$41.60
Volume102,345 shs
Average Volume3.45 million shs
Market Capitalization$2.36 billion
P/E RatioN/A
Dividend Yield6.08%
Beta2.59
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
Phone302-773-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.53 billion
Cash Flow$3.96 per share
Book Value$4.24 per share

Profitability

Net Income$-52,000,000.00

Miscellaneous

Employees7,000
Market Cap$2.36 billion
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Chemours (NYSE:CC) Frequently Asked Questions

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Wednesday, February 12th. Shareholders of record on Thursday, February 27th will be given a dividend of $0.25 per share on Monday, March 16th. This represents a $1.00 dividend on an annualized basis and a yield of 6.43%. The ex-dividend date is Wednesday, February 26th. View Chemours' Dividend History.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) issued its earnings results on Thursday, February, 13th. The specialty chemicals company reported $0.56 EPS for the quarter, beating analysts' consensus estimates of $0.42 by $0.14. The specialty chemicals company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. Chemours had a negative net margin of 0.92% and a positive return on equity of 52.65%. View Chemours' Earnings History.

When is Chemours' next earnings date?

Chemours is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for Chemours.

What guidance has Chemours issued on next quarter's earnings?

Chemours issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share guidance of $2.60-$3.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.22.

What price target have analysts set for CC?

12 analysts have issued 1-year price targets for Chemours' stock. Their forecasts range from $14.50 to $42.00. On average, they anticipate Chemours' share price to reach $23.15 in the next year. This suggests a possible upside of 48.9% from the stock's current price. View Analyst Price Targets for Chemours.

What is the consensus analysts' recommendation for Chemours?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 7 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemours.

Has Chemours been receiving favorable news coverage?

News coverage about CC stock has been trending negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Chemours earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Chemours.

Are investors shorting Chemours?

Chemours saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 15,830,000 shares, an increase of 9.0% from the January 30th total of 14,520,000 shares. Based on an average trading volume of 2,560,000 shares, the short-interest ratio is currently 6.2 days. Currently, 9.8% of the shares of the stock are sold short. View Chemours' Current Options Chain.

Who are some of Chemours' key competitors?

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), NVIDIA (NVDA), Micron Technology (MU), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Energy Transfer LP Unit (ET), Johnson & Johnson (JNJ), Pfizer (PFE) and DowDuPont (DWDP).

Who are Chemours' key executives?

Chemours' management team includes the folowing people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)

Who are Chemours' major shareholders?

Chemours' stock is owned by many different of institutional and retail investors. Top institutional shareholders include FMR LLC (14.54%), LSV Asset Management (2.53%), State Street Corp (2.42%), Bank of New York Mellon Corp (1.95%), Geode Capital Management LLC (1.10%) and Charles Schwab Investment Management Inc. (0.84%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.

Which major investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Alberta Investment Management Corp, Connor Clark & Lunn Investment Management Ltd., W.E. Donoghue & Co. LLC, Envestnet Asset Management Inc., Robeco Institutional Asset Management B.V., NEXT Financial Group Inc and Acadian Asset Management LLC. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman and Mark P Vergnano. View Insider Buying and Selling for Chemours.

Which major investors are buying Chemours stock?

CC stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, Great Lakes Advisors LLC, Bank of New York Mellon Corp, First Trust Advisors LP, Anavon Capital LLP, Blackcrane Capital LLC, DT Investment Partners LLC and UBS Asset Management Americas Inc.. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $15.55.

How big of a company is Chemours?

Chemours has a market capitalization of $2.55 billion and generates $5.53 billion in revenue each year. The specialty chemicals company earns $-52,000,000.00 in net income (profit) each year or $2.51 on an earnings per share basis. Chemours employs 7,000 workers across the globe.View Additional Information About Chemours.

What is Chemours' official website?

The official website for Chemours is http://www.chemours.com/.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for Chemours (NYSE CC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  557 (Vote Outperform)
Underperform Votes:  622 (Vote Underperform)
Total Votes:  1,179
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel